Filter
1004
Text search:
refugee
camps
Featured
Recommendations
118
New Publications
278
Language
Document type
No document type
538
Studies & Reports
185
Guidelines
108
Manuals
62
Strategic & Response Plan
41
Situation Updates
26
Fact sheets
23
Training Material
12
Brochures
2
Infographics
2
Online Courses
2
Videos
2
Resource Platforms
1
Countries / Regions
Syria
83
Bangladesh
59
Myanmar / Burma
54
Global
41
South Sudan
39
Ethiopia
28
Western and Central Europe
27
Lebanon
25
Kenya
25
Congo, Democratic Republic of
22
Rwanda
20
Uganda
18
Jordan
15
Nigeria
14
Africa
14
Afghanistan
11
Central African Republic
10
Yemen
10
Liberia
9
Germany
9
Sudan
9
West and Central Africa
9
Turkey
8
Tanzania
8
East and Southern Africa
8
Zambia
7
South Africa
7
Ukraine
7
Palestine
7
Senegal
6
India
6
Somalia
6
Nepal
6
Iraq
6
Greece
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Venezuela
6
Zimbabwe
5
Haiti
5
Malawi
5
Middle East and North Africa
5
Sierra Leone
4
Ghana
4
Cambodia
4
Burundi
4
Latin America and the Carribbean
4
Burkina Faso
3
Philippines
3
Pakistan
3
Mozambique
3
Colombia
3
Eastern Europe
3
Egypt
2
Thailand
2
Indonesia
2
Botswana
2
Libya
2
Mexico
2
Moldova
2
Guinea
1
Mali
1
Cameroon
1
Niger
1
Togo
1
Chad
1
China
1
Singapore
1
Brazil
1
Croatia
1
Madagascar
1
Asia
1
Italy
1
Canada
1
Timor Leste/ East Timor
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
296
Key Resources
89
Women & Child Health
59
Public Health
40
Clinical Guidelines
39
Capacity Building
18
Annual Report MEDBOX
1
Toolboxes
COVID-19
150
Conflict
144
Refugee
118
Mental Health
80
Disability
67
TB
35
Natural Hazards
29
HIV
28
Planetary Health
24
Rapid Response
21
Cholera
16
Global Health Education
11
Polio
10
Ebola
9
NTDs
8
Caregiver
7
AMR
5
Specific Hazards
4
Pharmacy
3
Health Financing Toolbox
3
South Sudan
2
Typhoon
1
Zika
1
Social Ethics
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
7 Febr. 2021
As COVID-19 continues to wreak havoc in countries – decimating people’s livelihoods, and leaving health systems struggling to provide healthcare and vaccines for the entire population - governments and donors should look to the Church as a partner. The essential Church networks, tr
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
In the present report, the Special Rapporteur on the sale and sexual exploitation of children, including child prostitution, child pornography and other child sexual abuse material, Mama Fatima Singhateh, focuses on the impact of the coronavirus disease (COVID-19) p
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
first issued 18 August 2022
Nutrition Surveys
The Good Enough Guide
recommended
A set of basic guidelines on how to be accountable to local people and measure program impact in emergency situations. The "good enough" approach emphasizes simple and practical solutions and encourages the user to choose tools that are safe, quick, and easy to implement
Assessing Mental Health and Psychosocial Needs and Resources Toolkit For Humanitarian Settings
recommended
Available in different languages: English, French, Arabic, Russian
Mental and Social Aspects of Health of Populations Exposed to Extreme Stressors
Training On The Misp For Sexual And Reproductive Health In Crisis Part 2
